Your browser doesn't support javascript.
loading
The Graded Incomplete Letters Test (GILT): a rapid test to detect cortical visual loss, with UK Biobank implementation.
Yong, Kxx; Petzold, A; Foster, P; Young, A; Bell, S; Bai, Y; Leff, A P; Crutch, S; Greenwood, J A.
Afiliação
  • Yong K; Queen Square Institute of Neurology, University College London, London, UK. keir.yong@ucl.ac.uk.
  • Petzold A; Queen Square Institute of Neurology, University College London, London, UK.
  • Foster P; Institute of Ophthalmology, University College London, London, UK.
  • Young A; Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Bell S; The National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK.
  • Bai Y; Neuro-ophthalmology Expertise Centre, Amsterdam UMC, Amsterdam, NL, The Netherlands.
  • Leff AP; Institute of Ophthalmology, University College London, London, UK.
  • Crutch S; Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Greenwood JA; Big Data Institute, Nuffield, Department of Population Health, University of Oxford, Oxford, UK.
Behav Res Methods ; 56(7): 7748-7760, 2024 10.
Article em En | MEDLINE | ID: mdl-38890263
ABSTRACT
Impairments of object recognition are core features of neurodegenerative syndromes, in particular posterior cortical atrophy (PCA; the 'visual-variant Alzheimer's disease'). These impairments arise from damage to higher-level cortical visual regions and are often missed or misattributed to common ophthalmological conditions. Consequently, diagnosis can be delayed for years with considerable implications for patients. We report a new test for the rapid measurement of cortical visual loss - the Graded Incomplete Letters Test (GILT). The GILT is an optimised psychophysical variation of a test used to diagnose cortical visual impairment, which measures thresholds for recognising letters under levels of increasing visual degradation (decreasing "completeness") in a similar fashion to ophthalmic tests. The GILT was administered to UK Biobank participants (total n=2,359) and participants with neurodegenerative conditions characterised by initial cortical visual (PCA, n=18) or memory loss (typical Alzheimer's disease, n=9). UK Biobank participants, including both typical adults and those with ophthalmological conditions, were able to recognise letters under low levels of completeness. In contrast, participants with PCA consistently made errors with only modest decreases in completeness. GILT sensitivity to PCA was 83.3% for participants reaching the 80% accuracy cut-off, increasing to 88.9% using alternative cut-offs (60% or 100% accuracy). Specificity values were consistently over 94% when compared to UK Biobank participants without or with documented visual conditions, regardless of accuracy cut-off. These first-release UK Biobank and clinical verification data suggest the GILT has utility in both rapidly detecting visual perceptual losses following posterior cortical damage and differentiating perceptual losses from common eye-related conditions.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Behav Res Methods Assunto da revista: CIENCIAS DO COMPORTAMENTO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Behav Res Methods Assunto da revista: CIENCIAS DO COMPORTAMENTO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido